CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −50,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −75,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −96,397 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −50,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Stock Options (right to buy) | −100,000 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Warrants (right to buy) | −133,334 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Warrants (right to buy) | −66,666 | 0 | ||
| 2018-11-16 | Naydenov Jordan G Director | Returned to the company · Warrants (right to buy) | −250,000 | 0 | ||
| 2018-11-08 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +1,000,000 | 1,000,000 | ||
| 2018-11-08 | Kelly Scott A. Director | Grant or award · Stock Options (right to buy) | +250,000 | 250,000 | ||
| 2018-11-08 | DOCKERY CARL Director | Grant or award · Stock Options (right to buy) | +250,000 | 250,000 | ||
| 2018-08-10 | Klump Michael A Director | Grant or award · Stock Option (right to buy) | +80,822 | 80,822 | ||
| 2018-06-08 | Mulholland Michael D. CFO, Treasurer and Secretary | Grant or award · Stock Options (right to buy) | +350,000 | 350,000 | ||
| 2018-06-08 | Pourhassan Nader President and CEO | Grant or award · Stock Options (right to buy) | +350,000 | 350,000 | ||
| 2018-06-08 | Montgomery Alan Bruce Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2018-06-08 | Caracciolo Anthony Executive Chairman | Grant or award · Stock Options (right to buy) | +950,000 | 950,000 | ||
| 2018-06-08 | BURGER DENIS R Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2018-06-08 | Gould Gregory A Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2018-06-08 | Kelly Scott A. Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 | ||
| 2018-06-08 | DOCKERY CARL Director | Grant or award · Stock Options (right to buy) | +100,000 | 100,000 |
Page 32 of 33 · 652 trades